Covered recipient · General Payments record
DYLAN P SCHUMACHER
Allopathic & Osteopathic Physicians Family Medicine Sports Medicine
General Payments · PY2024
$319.07
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $319.07 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $69.47 | 4 |
| ABBVIE INC. | $42.53 | 2 |
| Lilly USA, LLC | $40.90 | 3 |
| Acerta Pharma LLC | $39.87 | 2 |
| Novo Nordisk AS | $32.93 | 2 |
| Radius Health, Inc. | $32.35 | 1 |
| EISAI INC. | $23.24 | 1 |
| Merck Sharp & Dohme Corporation | $21.59 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $16.19 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $319.07 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.81 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043478 | CMS |
| ABBVIE INC. | $21.72 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106043480 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.45 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105725297 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.42 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366769 | CMS |
| Eisai Inc. | $23.24 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110742787 | CMS |
| Lilly USA, LLC | $13.31 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134964799 | CMS |
| Lilly USA, LLC | $13.89 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136154670 | CMS |
| Lilly USA, LLC | $13.70 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136145149 | CMS |
| Merck Sharp & Dohme LLC | $21.59 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141745495 | CMS |
| Novo Nordisk Inc | $16.42 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097057149 | CMS |
| Novo Nordisk Inc | $16.51 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097829826 | CMS |
| PFIZER INC. | $18.16 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131523547 | CMS |
| PFIZER INC. | $16.24 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131518957 | CMS |
| PFIZER INC. | $15.25 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131564021 | CMS |
| PFIZER INC. | $19.82 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131518349 | CMS |
| Radius Health, Inc. | $32.35 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089948441 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $16.19 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105923727 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.